Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 52 citing articles:

Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 142
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 86
Immunometabolism of tumor-associated macrophages: a therapeutic perspective
A. F. Karimova, Adelya R. Khalitova, Роман В. Суезов, et al.
European Journal of Cancer (2025), pp. 115332-115332
Open Access | Times Cited: 3
The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity
Md Nabiul Hasan, Okan Capuk, Shivani M. Patel, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3331-3331
Open Access | Times Cited: 40
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization
Sumei Chen, Haitao Zhu, Youssef Jounaïdi
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
Erin E Peterson, Kevin C. Barry
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 55
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2500-2500
Open Access | Times Cited: 53
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
Constance Baer, Shunsuke Kimura, Mitra S. Rana, et al.
Nature Genetics (2022) Vol. 54, Iss. 5, pp. 637-648
Open Access | Times Cited: 32
Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
Xuejun Shao, Shenghao Hua, Tao Feng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11789-11789
Open Access | Times Cited: 30
The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
Meike Kaulfuß, Juliane Mietz, Astrid Fabri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review)
Анна Казакова, Tatiana Sudarskikh, Oleg I. Kovalev, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 2
Open Access | Times Cited: 17
Benralizumab affects NK cell maturation and proliferation in severe asthmatic patients
Laura Bergantini, Miriana d’Alessandro, Tommaso Pianigiani, et al.
Clinical Immunology (2023) Vol. 253, pp. 109680-109680
Open Access | Times Cited: 15
Therapeutic exploitation of neutrophils to fight cancer
Mandy Gruijs, Celine Angeli Natascha Sewnath, Marjolein van Egmond
Seminars in Immunology (2021) Vol. 57, pp. 101581-101581
Open Access | Times Cited: 29
Therapeutic utility of engineered myeloid cells in the tumor microenvironment
Alessandro Canella, Prajwal Rajappa
Cancer Gene Therapy (2023) Vol. 30, Iss. 7, pp. 964-972
Open Access | Times Cited: 13
Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors
Yuexin Xu, Chris P. Miller, Scott S. Tykodi, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
Yuxiang Huang, Hengjian Liao, Jiefu Luo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
The stress-immune system axis: Exploring the interplay between stress and immunity
Muhammad Liaquat Raza
Progress in brain research (2025)
Closed Access
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
Ecem Kalemoglu, Yash Jani, Kübra Canaslan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Mechanisms of Immunosuppressive Tumor Evasion: Focus on Acute Lymphoblastic Leukemia
Silvia Jiménez‐Morales, Iván Sammir Aranda-Uribe, Carlos Jhovani Pérez-Amado, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis
Maria Teresa Palano, Matteo Gallazzi, Martina Cucchiara, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1488-1488
Open Access | Times Cited: 21
NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment
Eleonora Russo, Mattia Laffranchi, Luana Tomaipitinca, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Traditional Chinese Medicine in Regulating Tumor Microenvironment
Ziwei Wang, Mengyao Li, Ling Bi, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 313-325
Open Access | Times Cited: 3
Targeting the MET gene: unveiling therapeutic opportunities in immunotherapy within the tumor immune microenvironment of non-small cell lung cancer
Lisha Ye, Wenjing Wang, Huihui Li, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 3
The role of macrophages in gastric cancer
Jiaqing Zhang, Can Hu, Ruolan Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top